AngioDynamics, Inc. Hits New 52-Week High of $16.04, Up 143.81%

AngioDynamics, Inc., a microcap company in the Pharmaceuticals & Biotechnology sector, has reached a significant milestone by hitting a new 52-week high of USD 16.04 on August 10, 2026. This achievement marks a remarkable increase from its 52-week low of USD 8.38, reflecting a substantial year-over-year performance of 143.81%. In comparison, the S&P 500 has shown a performance of 21.34% over the same period, highlighting AngioDynamics' strong relative performance within the market. With a market capitalization of USD 453 million, AngioDynamics operates in a competitive industry characterized by innovation and growth potential. The company's financial metrics indicate a challenging environment, as it currently reports a negative return on equity of -8.98% and a debt-to-equity ratio of -0.23. Despite these figures, the stock's recent price movement underscores a notable shift in market dynamics. Investors and market observers will be keen to monitor how AngioDynamics continues to navigate its operational landscape following this significant price achievement.